Search clinical trials for: Buprenorphine naloxone (Suboxone)

Total 700 results

Indivior Inc.

Completed

Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME") (RIME)

Opioid Dependency

France
Indivior Inc.
Taipei City Psychiatric Center, Taiwan

Completed

Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan

Opiate Dependence

Taiwan
Wake Forest University Health Sciences

Withdrawn

Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films

Opioid Use
Indivior Inc.

Completed

Transfer of Subjects From Subutex/Suboxone to RBP-6300

Opioid Related Disorder

Austria, Czech Republic, Germany, Sweden
Massachusetts General Hospital

Not yet recruiting

Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients

Post-operative Pain

United States
Maimonides Medical Center

Terminated

Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients

Opioid Use Disorder

United States
Vertex Pharmaceuticals Incorporated
Tibotec BVBA

Completed

Drug-Drug Interaction Study Between Telaprevir and Buprenorphine

Hepatitis C | Opioid-Related Disorders

United States
University of British Columbia

Recruiting

Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments

Opioid-use Disorder

Canada
State University of New York at Buffalo

Terminated

Buprenorphine as a Treatment in Opiate Dependent Pain Patients

Opiate Addiction | Refractory Pain

United States
New York State Psychiatric Institute

Completed

Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse (PAIN)

Opioid Dependence

United States
Friends Research Institute, Inc.
MATClinics

Recruiting

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

Opioid Use Disorder

United States
NYU Langone Health
Emergency Medicine Foundation

Completed

Buprenorphine Loading in the Emergency Department

Opioid-use Disorder

United States
Massachusetts General Hospital

Not yet recruiting

A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms

Opioid-use Disorder | Opioid Use Disorder, Mild
Yale University
National Institute on Drug Abuse (NIDA); Howard University; George Mason University

Completed

HIV, Buprenorphine, and the Criminal Justice System (STRIDE)

Acquired Immunodeficiency Syndrome | Human Immunodeficiency Virus | Opiate Addiction | Drug Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

Opioid Dependence

United States
Indivior Inc.

Completed

Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)

Opioid-Related Disorders | Drug Abuse | Opiate Dependence

Austria
Indivior Inc.

Completed

Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder

Opioid Use Disorder

United States
University of California, Davis
Yale University; University of Utah

Not yet recruiting

Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder (PEDsTREATOUD)

Opioid-use Disorder
Indivior Inc.

Completed

Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)

Opioid-Related Disorders | Drug Abuse | Opiate Dependence
Stony Brook University

Withdrawn

Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology

Opioid-use Disorder
VA Office of Research and Development

Terminated

Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain (Bup)

Pain

United States
Indivior Inc.

Completed

Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder

Opioid Use Disorder | Opioid-related Disorders

United States
Indivior Inc.

Completed

Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone

Opioid-related Disorders

United States
Indivior Inc.

Completed

Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)

Drug Abuse | Opiate Dependence | Opiate-related Disorders
Indivior Inc.

Completed

A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)

Opiate Dependence | Drug Dependence
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Maternal Buprenorphine-naloxone Treatment and the Infant

Maternal Opioid Use Disorder | Opioid Exposed Infant

United States
University of British Columbia
Vancouver Coastal Health

Recruiting

Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Opioid Use Disorder

Canada
Indivior Inc.

Completed

Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder

Healthy Volunteer | Opioid-use Disorder

United States
University of Wisconsin, Madison

Completed

Dane County Drug Court Study for Addicted Offenders

Opioid Dependence

United States
Indivior Inc.

Completed

Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population

Opioid Dependence

United States
State University of New York at Buffalo

Withdrawn

Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents

Opiate Addiction

United States
NanoSHIFT LLC

Completed

Study to Assess the PK Profile of NanoBUP Capsules Relative to Suboxone

Healthy

United States
Emory University
National Institute on Drug Abuse (NIDA); Chestnut Health Systems

Withdrawn

Adolescent Community Reinforcement Approach in Combination With Buprenorphine/Naloxone for Severe Opioid Use (A-CRA/MAT)

Behavior, Addictive | Opioid-Related Disorders
University of California, Los Angeles
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Cocaine Use Reduction With Buprenorphine (CURB)

Cocaine Dependence

United States
Oregon Health and Science University
Hanoi Medical University; Hennepin Healthcare Research Institute

Completed

Buprenorphine to Improve HIV Care Engagement and Outcomes (BRAVO)

HIV | Substance Related Disorders

Vietnam
NYU Langone Health
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

Opioid Use Disorder

United States
Didier Jutras Aswad
Canadian Institutes of Health Research (CIHR)

Completed

A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse (OPTIMA)

Opioid Use Disorder

Canada
State University of New York at Buffalo
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse...

Completed

Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients

Opiate Addiction

United States
Astellas Pharma Global Development, Inc.
National Institute on Drug Abuse (NIDA)

Completed

A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder

Opioid Use Disorder

United States
State University of New York at Buffalo

Completed

Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients

Low Back Pain

United States
Lifespan
The Miriam Hospital; University of Rhode Island

Active, not recruiting

Medication Maintenance Therapy in Community Pharmacy Settings (MATPharm)

Opioid-use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Naltrexone-P1 A-Cocaine

Cocaine-related Disorders

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

HIV Risk Reduction in Subutex Injectors in Tbilisi

HIV

Georgia
Paolo Mannelli
Alkermes, Inc.

Completed

Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence (BUP/NXT-VIVI)

Opiate Dependence

United States
University of Pennsylvania
National Institute of Drug Abuse; The Wistar Institute; Ho Chi Minh City CDC; Institute...

Recruiting

Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1 (AMOHI-1)

Inflammation | Opioid-use Disorder | HIV-1-infection | Immune Activation | Buprenorphine | Methadone | Naltrexone | Antiretroviral Treatment

United States, Vietnam
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine for Prisoners

Heroin Addiction

United States
University of Oslo
Norwegian Institute of Public Health; Oslo University Hospital; The Research... and other collaborators

Completed

Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway (NTX-SBX)

Opioid Dependence

Norway
Indivior Inc.

Completed

Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder

Opioid Use Disorder

United States
Ruth M. Rothstein CORE Center
Health Resources and Services Administration (HRSA); The New York Academy of...

Completed

The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration (BUP)

HIV Infections | Post-Traumatic Stress Disorders | Opiate Dependence | AIDS

United States
Indivior Inc.

Completed

Single Ascending Dose Study of RBP-6000 (SAD)

Opioid Use Disorder

United States

Search clinical trials for: Buprenorphine naloxone (Suboxone)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations